AI assistant
SYNECTICS PLC Major Shareholding Notification 2024
7942_mrq_2024-08-21_4c584618-751e-4607-b30c-c53d6818f363.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 1699B
Synectics PLC
21 August 2024
| 21 August 2024 |
Synectics plc
("Synectics" or the "Company")
Notifiable Interest in Shares
Synectics, a leader in advanced security and surveillance systems, was notified on 20 August 2024, that the estate of David Coghlan, former Chair, no longer holds a notifiable interest in the share capital of the Company.
For further information, please contact:
| Synectics plc Paul Webb, Chief Executive Officer Amanda Larnder, Chief Financial Officer Claire Stewart, Company Secretary [email protected] |
Tel: +44 (0) 114 280 2828 www.synecticsplc.com |
| Shore Capital | Tel: +44 (0) 20 7408 4090 |
| Tom Griffiths / David Coaten / Rachel Goldstein | |
| Vigo Consulting | Tel: +44 (0) 20 7390 0230 |
| Jeremy Garcia / Fiona Hetherington / Peter Jacob [email protected] |
About Synectics plc
Synectics plc (AIM: SNX) is a leader in advanced security and surveillance systems that help protect people, property, communities, and assets around the world.
The Company's expertise is in providing solutions for specific markets where security and surveillance are critical to operations. These include gaming, oil and gas, public space, transport, and critical infrastructure.
Synectics has deep industry experience in these markets and works closely with customers globally to deliver solutions that are tailored to meet their needs. Technical excellence, combined with decades of experience and long-standing customer relationships, provides fundamental differentiation from mainstream suppliers and makes the Company a stand-out in its field.
Find out more at www.synecticsplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCQKKBPCBKDCFB